nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—IKBKB—Auranofin—psoriatic arthritis	0.833	0.958	CbGbCtD
Acetylcysteine—SLCO1B1—Methotrexate—psoriatic arthritis	0.022	0.0253	CbGbCtD
Acetylcysteine—SLC22A6—Methotrexate—psoriatic arthritis	0.0141	0.0162	CbGbCtD
Acetylcysteine—Erythema facial—Prednisolone—psoriatic arthritis	0.00382	0.0664	CcSEcCtD
Acetylcysteine—IKBKB—IL17 signaling pathway—TRAF3IP2—psoriatic arthritis	0.00369	0.054	CbGpPWpGaD
Acetylcysteine—Erythema facial—Methylprednisolone—psoriatic arthritis	0.00351	0.0609	CcSEcCtD
Acetylcysteine—Erythema facial—Dexamethasone—psoriatic arthritis	0.00319	0.0554	CcSEcCtD
Acetylcysteine—Erythema facial—Betamethasone—psoriatic arthritis	0.00319	0.0554	CcSEcCtD
Acetylcysteine—Erythema facial—Prednisone—psoriatic arthritis	0.00278	0.0482	CcSEcCtD
Acetylcysteine—IKBKB—Atypical NF-kappaB pathway—REL—psoriatic arthritis	0.0025	0.0366	CbGpPWpGaD
Acetylcysteine—CHUK—NOD pathway—MEFV—psoriatic arthritis	0.0021	0.0307	CbGpPWpGaD
Acetylcysteine—IKBKB—NOD pathway—MEFV—psoriatic arthritis	0.0019	0.0278	CbGpPWpGaD
Acetylcysteine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—psoriatic arthritis	0.00179	0.0262	CbGpPWpGaD
Acetylcysteine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—psoriatic arthritis	0.00162	0.0238	CbGpPWpGaD
Acetylcysteine—CHUK—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.00125	0.0184	CbGpPWpGaD
Acetylcysteine—Stomatitis—Auranofin—psoriatic arthritis	0.00119	0.0207	CcSEcCtD
Acetylcysteine—IKBKB—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.00114	0.0166	CbGpPWpGaD
Acetylcysteine—CHUK—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—psoriatic arthritis	0.00114	0.0166	CbGpPWpGaD
Acetylcysteine—IKBKB—IL17 signaling pathway—IL17A—psoriatic arthritis	0.00111	0.0163	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—LTA—psoriatic arthritis	0.00108	0.0158	CbGpPWpGaD
Acetylcysteine—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—psoriatic arthritis	0.00103	0.0151	CbGpPWpGaD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNFRSF1B—psoriatic arthritis	0.001	0.0147	CbGpPWpGaD
Acetylcysteine—CHUK—NOD1/2 Signaling Pathway—NOD2—psoriatic arthritis	0.000987	0.0145	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—LTA—psoriatic arthritis	0.00098	0.0143	CbGpPWpGaD
Acetylcysteine—CHUK—IL-1 signaling pathway—REL—psoriatic arthritis	0.000922	0.0135	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNFRSF1B—psoriatic arthritis	0.000911	0.0133	CbGpPWpGaD
Acetylcysteine—IKBKB—NOD1/2 Signaling Pathway—NOD2—psoriatic arthritis	0.000895	0.0131	CbGpPWpGaD
Acetylcysteine—Angioedema—Auranofin—psoriatic arthritis	0.000875	0.0152	CcSEcCtD
Acetylcysteine—IKBKB—IL-1 signaling pathway—REL—psoriatic arthritis	0.000836	0.0122	CbGpPWpGaD
Acetylcysteine—CHUK—Activation of NF-kappaB in B cells—REL—psoriatic arthritis	0.000807	0.0118	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-1 signaling—NOD2—psoriatic arthritis	0.000805	0.0118	CbGpPWpGaD
Acetylcysteine—CHUK—NOD pathway—NOD2—psoriatic arthritis	0.000789	0.0116	CbGpPWpGaD
Acetylcysteine—IKBKB—Activation of NF-kappaB in B cells—REL—psoriatic arthritis	0.000732	0.0107	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-1 signaling—NOD2—psoriatic arthritis	0.00073	0.0107	CbGpPWpGaD
Acetylcysteine—CHUK—Leptin signaling pathway—REL—psoriatic arthritis	0.00072	0.0105	CbGpPWpGaD
Acetylcysteine—IKBKB—NOD pathway—NOD2—psoriatic arthritis	0.000716	0.0105	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Auranofin—psoriatic arthritis	0.000688	0.0119	CcSEcCtD
Acetylcysteine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—psoriatic arthritis	0.000674	0.00986	CbGpPWpGaD
Acetylcysteine—IKBKB—Leptin signaling pathway—REL—psoriatic arthritis	0.000652	0.00955	CbGpPWpGaD
Acetylcysteine—Wheezing—Triamcinolone—psoriatic arthritis	0.000624	0.0108	CcSEcCtD
Acetylcysteine—CHUK—TCR Signaling Pathway—REL—psoriatic arthritis	0.000622	0.0091	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNFRSF1B—psoriatic arthritis	0.000621	0.00909	CbGpPWpGaD
Acetylcysteine—Urticaria—Auranofin—psoriatic arthritis	0.000621	0.0108	CcSEcCtD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.000611	0.00895	CbGpPWpGaD
Acetylcysteine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—psoriatic arthritis	0.000611	0.00894	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—REL—psoriatic arthritis	0.000586	0.00857	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.000577	0.00845	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—REL—psoriatic arthritis	0.000564	0.00826	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TNFRSF1B—psoriatic arthritis	0.000563	0.00824	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.000554	0.00811	CbGpPWpGaD
Acetylcysteine—Pruritus—Auranofin—psoriatic arthritis	0.000553	0.00959	CcSEcCtD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000542	0.00793	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.000537	0.00787	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—REL—psoriatic arthritis	0.000531	0.00778	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TNFRSF1B—psoriatic arthritis	0.000528	0.00773	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.000524	0.00909	CcSEcCtD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL17A—psoriatic arthritis	0.000523	0.00766	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.000523	0.00766	CbGpPWpGaD
Acetylcysteine—Vomiting—Auranofin—psoriatic arthritis	0.000497	0.00862	CcSEcCtD
Acetylcysteine—Rash—Auranofin—psoriatic arthritis	0.000493	0.00855	CcSEcCtD
Acetylcysteine—Dermatitis—Auranofin—psoriatic arthritis	0.000492	0.00854	CcSEcCtD
Acetylcysteine—IKBKB—Downstream TCR signaling—HLA-DRB1—psoriatic arthritis	0.000487	0.00713	CbGpPWpGaD
Acetylcysteine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.000487	0.00713	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.000482	0.00836	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00048	0.00834	CcSEcCtD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL17A—psoriatic arthritis	0.000475	0.00695	CbGpPWpGaD
Acetylcysteine—Eye pain—Dexamethasone—psoriatic arthritis	0.000468	0.00813	CcSEcCtD
Acetylcysteine—Eye pain—Betamethasone—psoriatic arthritis	0.000468	0.00813	CcSEcCtD
Acetylcysteine—SLC7A11—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000468	0.105	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000468	0.105	CbGdCrCtD
Acetylcysteine—Nausea—Auranofin—psoriatic arthritis	0.000464	0.00806	CcSEcCtD
Acetylcysteine—SLC7A11—Betamethasone—Dexamethasone—psoriatic arthritis	0.000461	0.104	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Betamethasone—psoriatic arthritis	0.000461	0.104	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Triamcinolone—psoriatic arthritis	0.00045	0.101	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00045	0.101	CbGdCrCtD
Acetylcysteine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.000442	0.00646	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000441	0.00645	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.00044	0.00645	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.000437	0.00758	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.000437	0.00758	CcSEcCtD
Acetylcysteine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000436	0.00639	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000429	0.00627	CbGpPWpGaD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisone—psoriatic arthritis	0.000427	0.0961	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisone—psoriatic arthritis	0.000427	0.0961	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisolone—psoriatic arthritis	0.000417	0.0938	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisolone—psoriatic arthritis	0.000417	0.0938	CbGdCrCtD
Acetylcysteine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000414	0.00605	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000407	0.00595	CbGpPWpGaD
Acetylcysteine—CHUK—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.000403	0.00591	CbGpPWpGaD
Acetylcysteine—CHUK—EBV LMP1 signaling—TNF—psoriatic arthritis	0.000403	0.00591	CbGpPWpGaD
Acetylcysteine—Asthma—Triamcinolone—psoriatic arthritis	0.000403	0.00699	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000402	0.00588	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.0004	0.00585	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000399	0.00584	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000396	0.00579	CbGpPWpGaD
Acetylcysteine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.000395	0.00686	CcSEcCtD
Acetylcysteine—CHUK—MyD88-independent cascade—NOD2—psoriatic arthritis	0.00039	0.00571	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000389	0.00569	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000379	0.00555	CbGpPWpGaD
Acetylcysteine—IKBKB—Type II diabetes mellitus—TNF—psoriatic arthritis	0.000379	0.00555	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000375	0.00549	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000369	0.0054	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.000367	0.00538	CbGpPWpGaD
Acetylcysteine—IKBKB—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.000366	0.00535	CbGpPWpGaD
Acetylcysteine—IKBKB—EBV LMP1 signaling—TNF—psoriatic arthritis	0.000366	0.00535	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000364	0.00533	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000364	0.00533	CbGpPWpGaD
Acetylcysteine—Face oedema—Prednisone—psoriatic arthritis	0.000356	0.00617	CcSEcCtD
Acetylcysteine—IKBKB—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000354	0.00518	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000351	0.00514	CbGpPWpGaD
Acetylcysteine—CHUK—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.00035	0.00512	CbGpPWpGaD
Acetylcysteine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000345	0.00506	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000344	0.00503	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000344	0.00503	CbGpPWpGaD
Acetylcysteine—Sweating—Methylprednisolone—psoriatic arthritis	0.000344	0.00596	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—REL—psoriatic arthritis	0.000335	0.0049	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HLA-C—psoriatic arthritis	0.000333	0.00488	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.000333	0.00487	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.00033	0.00483	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—NOD2—psoriatic arthritis	0.00033	0.00483	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—NOS2—psoriatic arthritis	0.000325	0.00475	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00032	0.00556	CcSEcCtD
Acetylcysteine—IKBKB—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000318	0.00466	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000318	0.00552	CcSEcCtD
Acetylcysteine—IKBKB—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000317	0.00464	CbGpPWpGaD
Acetylcysteine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000313	0.00459	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000312	0.00456	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—TNF—psoriatic arthritis	0.00031	0.00454	CbGpPWpGaD
Acetylcysteine—Erythema—Prednisolone—psoriatic arthritis	0.000305	0.0053	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—REL—psoriatic arthritis	0.000304	0.00445	CbGpPWpGaD
Acetylcysteine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—psoriatic arthritis	0.000302	0.00442	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000299	0.00438	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000299	0.00518	CcSEcCtD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000294	0.0043	CbGpPWpGaD
Acetylcysteine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000292	0.00507	CcSEcCtD
Acetylcysteine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000291	0.00504	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00029	0.00503	CcSEcCtD
Acetylcysteine—Erythema—Triamcinolone—psoriatic arthritis	0.000281	0.00487	CcSEcCtD
Acetylcysteine—Erythema—Methylprednisolone—psoriatic arthritis	0.00028	0.00486	CcSEcCtD
Acetylcysteine—Angioedema—Prednisolone—psoriatic arthritis	0.000279	0.00484	CcSEcCtD
Acetylcysteine—Syncope—Prednisolone—psoriatic arthritis	0.000274	0.00475	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000268	0.00466	CcSEcCtD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000266	0.0039	CbGpPWpGaD
Acetylcysteine—Asthma—Methotrexate—psoriatic arthritis	0.000266	0.00462	CcSEcCtD
Acetylcysteine—Angiopathy—Betamethasone—psoriatic arthritis	0.000265	0.00461	CcSEcCtD
Acetylcysteine—Angiopathy—Dexamethasone—psoriatic arthritis	0.000265	0.00461	CcSEcCtD
Acetylcysteine—Angioedema—Triamcinolone—psoriatic arthritis	0.000256	0.00445	CcSEcCtD
Acetylcysteine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000256	0.00444	CcSEcCtD
Acetylcysteine—GRIN2A—Alzheimers Disease—TNF—psoriatic arthritis	0.000255	0.00373	CbGpPWpGaD
Acetylcysteine—Erythema—Betamethasone—psoriatic arthritis	0.000255	0.00442	CcSEcCtD
Acetylcysteine—Erythema—Dexamethasone—psoriatic arthritis	0.000255	0.00442	CcSEcCtD
Acetylcysteine—CHUK—Innate Immune System—MEFV—psoriatic arthritis	0.000253	0.0037	CbGpPWpGaD
Acetylcysteine—Syncope—Triamcinolone—psoriatic arthritis	0.000252	0.00437	CcSEcCtD
Acetylcysteine—Syncope—Methylprednisolone—psoriatic arthritis	0.000251	0.00436	CcSEcCtD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000249	0.00365	CbGpPWpGaD
Acetylcysteine—Oedema—Prednisolone—psoriatic arthritis	0.000249	0.00432	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000249	0.00432	CcSEcCtD
Acetylcysteine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000247	0.00428	CcSEcCtD
Acetylcysteine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000246	0.00427	CcSEcCtD
Acetylcysteine—Shock—Prednisolone—psoriatic arthritis	0.000245	0.00425	CcSEcCtD
Acetylcysteine—Cough—Triamcinolone—psoriatic arthritis	0.000245	0.00425	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisolone—psoriatic arthritis	0.000243	0.00422	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000241	0.00418	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—psoriatic arthritis	0.000237	0.00412	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000237	0.00411	CcSEcCtD
Acetylcysteine—Flushing—Prednisone—psoriatic arthritis	0.000236	0.0041	CcSEcCtD
Acetylcysteine—Angioedema—Betamethasone—psoriatic arthritis	0.000233	0.00404	CcSEcCtD
Acetylcysteine—Angioedema—Dexamethasone—psoriatic arthritis	0.000233	0.00404	CcSEcCtD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNF—psoriatic arthritis	0.000232	0.00339	CbGpPWpGaD
Acetylcysteine—Stomatitis—Methotrexate—psoriatic arthritis	0.000231	0.00401	CcSEcCtD
Acetylcysteine—Angiopathy—Prednisone—psoriatic arthritis	0.000231	0.00401	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000231	0.00338	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Prednisone—psoriatic arthritis	0.00023	0.00399	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—MEFV—psoriatic arthritis	0.000229	0.00336	CbGpPWpGaD
Acetylcysteine—Oedema—Triamcinolone—psoriatic arthritis	0.000229	0.00398	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000229	0.00398	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000229	0.00397	CcSEcCtD
Acetylcysteine—Syncope—Betamethasone—psoriatic arthritis	0.000228	0.00396	CcSEcCtD
Acetylcysteine—Syncope—Dexamethasone—psoriatic arthritis	0.000228	0.00396	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—psoriatic arthritis	0.000227	0.00395	CcSEcCtD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000226	0.00331	CbGpPWpGaD
Acetylcysteine—Shock—Triamcinolone—psoriatic arthritis	0.000225	0.00391	CcSEcCtD
Acetylcysteine—Shock—Methylprednisolone—psoriatic arthritis	0.000225	0.0039	CcSEcCtD
Acetylcysteine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000224	0.00389	CcSEcCtD
Acetylcysteine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000224	0.00389	CcSEcCtD
Acetylcysteine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000224	0.00388	CcSEcCtD
Acetylcysteine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000223	0.00387	CcSEcCtD
Acetylcysteine—GRIN1—Alzheimers Disease—TNF—psoriatic arthritis	0.000222	0.00325	CbGpPWpGaD
Acetylcysteine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000222	0.00385	CcSEcCtD
Acetylcysteine—Erythema—Prednisone—psoriatic arthritis	0.000222	0.00385	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000221	0.00384	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000221	0.00384	CcSEcCtD
Acetylcysteine—GRIN2B—Alzheimers Disease—TNF—psoriatic arthritis	0.000217	0.00317	CbGpPWpGaD
Acetylcysteine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000214	0.00371	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000211	0.00367	CcSEcCtD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNF—psoriatic arthritis	0.00021	0.00308	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000209	0.00306	CbGpPWpGaD
Acetylcysteine—Oedema—Betamethasone—psoriatic arthritis	0.000208	0.00361	CcSEcCtD
Acetylcysteine—Oedema—Dexamethasone—psoriatic arthritis	0.000208	0.00361	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000208	0.00361	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000208	0.00361	CcSEcCtD
Acetylcysteine—Shock—Dexamethasone—psoriatic arthritis	0.000204	0.00355	CcSEcCtD
Acetylcysteine—Shock—Betamethasone—psoriatic arthritis	0.000204	0.00355	CcSEcCtD
Acetylcysteine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000204	0.00355	CcSEcCtD
Acetylcysteine—Tachycardia—Betamethasone—psoriatic arthritis	0.000203	0.00352	CcSEcCtD
Acetylcysteine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000203	0.00352	CcSEcCtD
Acetylcysteine—Angioedema—Prednisone—psoriatic arthritis	0.000203	0.00352	CcSEcCtD
Acetylcysteine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000202	0.0035	CcSEcCtD
Acetylcysteine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000201	0.00349	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000201	0.00349	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000201	0.00349	CcSEcCtD
Acetylcysteine—CHUK—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000201	0.00294	CbGpPWpGaD
Acetylcysteine—Syncope—Prednisone—psoriatic arthritis	0.000199	0.00345	CcSEcCtD
Acetylcysteine—Urticaria—Prednisolone—psoriatic arthritis	0.000198	0.00344	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000198	0.00343	CcSEcCtD
Acetylcysteine—CHUK—DAP12 interactions—HLA-B—psoriatic arthritis	0.000197	0.00288	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000195	0.00338	CcSEcCtD
Acetylcysteine—Hypotension—Betamethasone—psoriatic arthritis	0.000194	0.00337	CcSEcCtD
Acetylcysteine—Hypotension—Dexamethasone—psoriatic arthritis	0.000194	0.00337	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—psoriatic arthritis	0.000193	0.00335	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000192	0.00334	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000192	0.00333	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000188	0.00326	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—psoriatic arthritis	0.000185	0.00322	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000184	0.00319	CcSEcCtD
Acetylcysteine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000183	0.00318	CcSEcCtD
Acetylcysteine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000183	0.00318	CcSEcCtD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000182	0.00267	CbGpPWpGaD
Acetylcysteine—Urticaria—Triamcinolone—psoriatic arthritis	0.000182	0.00316	CcSEcCtD
Acetylcysteine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000182	0.00315	CcSEcCtD
Acetylcysteine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000181	0.00314	CcSEcCtD
Acetylcysteine—Oedema—Prednisone—psoriatic arthritis	0.000181	0.00314	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000181	0.00314	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000179	0.00312	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000179	0.00312	CcSEcCtD
Acetylcysteine—Shock—Prednisone—psoriatic arthritis	0.000178	0.00309	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisone—psoriatic arthritis	0.000177	0.00307	CcSEcCtD
Acetylcysteine—Skin disorder—Prednisone—psoriatic arthritis	0.000176	0.00305	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000175	0.00304	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.00017	0.00249	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000169	0.00293	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000168	0.00292	CcSEcCtD
Acetylcysteine—Urticaria—Betamethasone—psoriatic arthritis	0.000165	0.00287	CcSEcCtD
Acetylcysteine—Urticaria—Dexamethasone—psoriatic arthritis	0.000165	0.00287	CcSEcCtD
Acetylcysteine—Dizziness—Prednisolone—psoriatic arthritis	0.000165	0.00286	CcSEcCtD
Acetylcysteine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000164	0.00285	CcSEcCtD
Acetylcysteine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000164	0.00285	CcSEcCtD
Acetylcysteine—Pruritus—Triamcinolone—psoriatic arthritis	0.000162	0.00281	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—psoriatic arthritis	0.000162	0.00281	CcSEcCtD
Acetylcysteine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000162	0.00281	CcSEcCtD
Acetylcysteine—GRIN1—Spinal Cord Injury—TNF—psoriatic arthritis	0.000161	0.00236	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Prednisone—psoriatic arthritis	0.000159	0.00277	CcSEcCtD
Acetylcysteine—Rash—Prednisolone—psoriatic arthritis	0.000157	0.00273	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisolone—psoriatic arthritis	0.000157	0.00272	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000157	0.00272	CcSEcCtD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000154	0.00225	CbGpPWpGaD
Acetylcysteine—Dizziness—Triamcinolone—psoriatic arthritis	0.000151	0.00263	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000151	0.00263	CcSEcCtD
Acetylcysteine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000151	0.00262	CcSEcCtD
Acetylcysteine—Nausea—Prednisolone—psoriatic arthritis	0.000148	0.00257	CcSEcCtD
Acetylcysteine—CHUK—Immune System—MEFV—psoriatic arthritis	0.000147	0.00216	CbGpPWpGaD
Acetylcysteine—Pruritus—Betamethasone—psoriatic arthritis	0.000147	0.00255	CcSEcCtD
Acetylcysteine—Pruritus—Dexamethasone—psoriatic arthritis	0.000147	0.00255	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—NOS2—psoriatic arthritis	0.000147	0.00215	CbGpPWpGaD
Acetylcysteine—Skin disorder—Methotrexate—psoriatic arthritis	0.000147	0.00255	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000146	0.00254	CcSEcCtD
Acetylcysteine—Vomiting—Triamcinolone—psoriatic arthritis	0.000146	0.00253	CcSEcCtD
Acetylcysteine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000145	0.00252	CcSEcCtD
Acetylcysteine—Rash—Triamcinolone—psoriatic arthritis	0.000144	0.00251	CcSEcCtD
Acetylcysteine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000144	0.0025	CcSEcCtD
Acetylcysteine—Rash—Methylprednisolone—psoriatic arthritis	0.000144	0.0025	CcSEcCtD
Acetylcysteine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000144	0.0025	CcSEcCtD
Acetylcysteine—Urticaria—Prednisone—psoriatic arthritis	0.000144	0.0025	CcSEcCtD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000143	0.0021	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNF—psoriatic arthritis	0.000143	0.0021	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Prednisone—psoriatic arthritis	0.000143	0.00248	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—psoriatic arthritis	0.000141	0.00245	CcSEcCtD
Acetylcysteine—Dizziness—Betamethasone—psoriatic arthritis	0.000137	0.00239	CcSEcCtD
Acetylcysteine—Dizziness—Dexamethasone—psoriatic arthritis	0.000137	0.00239	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000137	0.002	CbGpPWpGaD
Acetylcysteine—Nausea—Triamcinolone—psoriatic arthritis	0.000136	0.00236	CcSEcCtD
Acetylcysteine—Nausea—Methylprednisolone—psoriatic arthritis	0.000136	0.00236	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—REL—psoriatic arthritis	0.000135	0.00198	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000135	0.00234	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—psoriatic arthritis	0.000134	0.00233	CcSEcCtD
Acetylcysteine—IKBKB—Immune System—MEFV—psoriatic arthritis	0.000134	0.00196	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000133	0.00232	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000133	0.00231	CcSEcCtD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000133	0.00195	CbGpPWpGaD
Acetylcysteine—Vomiting—Dexamethasone—psoriatic arthritis	0.000132	0.00229	CcSEcCtD
Acetylcysteine—Vomiting—Betamethasone—psoriatic arthritis	0.000132	0.00229	CcSEcCtD
Acetylcysteine—Rash—Dexamethasone—psoriatic arthritis	0.000131	0.00227	CcSEcCtD
Acetylcysteine—Rash—Betamethasone—psoriatic arthritis	0.000131	0.00227	CcSEcCtD
Acetylcysteine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000131	0.00227	CcSEcCtD
Acetylcysteine—Dermatitis—Betamethasone—psoriatic arthritis	0.000131	0.00227	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000131	0.00227	CcSEcCtD
Acetylcysteine—IKBKB—Apoptosis—TNF—psoriatic arthritis	0.00013	0.0019	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.00013	0.0019	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-C—psoriatic arthritis	0.000129	0.0019	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.000129	0.00189	CbGpPWpGaD
Acetylcysteine—Pruritus—Prednisone—psoriatic arthritis	0.000128	0.00222	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000124	0.00182	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000124	0.00181	CbGpPWpGaD
Acetylcysteine—Nausea—Dexamethasone—psoriatic arthritis	0.000123	0.00214	CcSEcCtD
Acetylcysteine—Nausea—Betamethasone—psoriatic arthritis	0.000123	0.00214	CcSEcCtD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000123	0.00179	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—REL—psoriatic arthritis	0.000122	0.00179	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000121	0.00177	CbGpPWpGaD
Acetylcysteine—Urticaria—Methotrexate—psoriatic arthritis	0.00012	0.00209	CcSEcCtD
Acetylcysteine—Dizziness—Prednisone—psoriatic arthritis	0.00012	0.00208	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—psoriatic arthritis	0.00012	0.00208	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—HLA-C—psoriatic arthritis	0.000117	0.00172	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000116	0.00169	CbGpPWpGaD
Acetylcysteine—Vomiting—Prednisone—psoriatic arthritis	0.000115	0.002	CcSEcCtD
Acetylcysteine—Rash—Prednisone—psoriatic arthritis	0.000114	0.00198	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisone—psoriatic arthritis	0.000114	0.00198	CcSEcCtD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000113	0.00165	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000111	0.00193	CcSEcCtD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000111	0.00163	CbGpPWpGaD
Acetylcysteine—Nausea—Prednisone—psoriatic arthritis	0.000108	0.00187	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—psoriatic arthritis	0.000107	0.00186	CcSEcCtD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000105	0.00153	CbGpPWpGaD
Acetylcysteine—Dizziness—Methotrexate—psoriatic arthritis	0.0001	0.00174	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—psoriatic arthritis	9.62e-05	0.00167	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	9.56e-05	0.0014	CbGpPWpGaD
Acetylcysteine—Rash—Methotrexate—psoriatic arthritis	9.54e-05	0.00166	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—psoriatic arthritis	9.53e-05	0.00165	CcSEcCtD
Acetylcysteine—CHUK—Innate Immune System—NOD2—psoriatic arthritis	9.52e-05	0.00139	CbGpPWpGaD
Acetylcysteine—Nausea—Methotrexate—psoriatic arthritis	8.99e-05	0.00156	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	8.67e-05	0.00127	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NOD2—psoriatic arthritis	8.63e-05	0.00126	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—REL—psoriatic arthritis	8.19e-05	0.0012	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-B—psoriatic arthritis	7.66e-05	0.00112	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-C—psoriatic arthritis	7.54e-05	0.0011	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—psoriatic arthritis	7.45e-05	0.00109	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—REL—psoriatic arthritis	7.43e-05	0.00109	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	7.42e-05	0.00109	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-B—psoriatic arthritis	7.35e-05	0.00108	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-B—psoriatic arthritis	6.94e-05	0.00102	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-C—psoriatic arthritis	6.84e-05	0.001	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CRP—psoriatic arthritis	6.77e-05	0.000991	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-B—psoriatic arthritis	6.67e-05	0.000976	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	6.22e-05	0.000911	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CRP—psoriatic arthritis	6.14e-05	0.000898	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.64e-05	0.000826	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NOD2—psoriatic arthritis	5.54e-05	0.000812	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—psoriatic arthritis	5.13e-05	0.000751	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NOD2—psoriatic arthritis	5.03e-05	0.000736	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—psoriatic arthritis	5e-05	0.000732	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-B—psoriatic arthritis	4.46e-05	0.000653	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-B—psoriatic arthritis	4.04e-05	0.000592	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—psoriatic arthritis	3.94e-05	0.000577	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-DRB1—psoriatic arthritis	3.77e-05	0.000553	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—psoriatic arthritis	3.57e-05	0.000523	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-DRB1—psoriatic arthritis	3.42e-05	0.000501	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS2—psoriatic arthritis	3.32e-05	0.000486	CbGpPWpGaD
